Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jun 11;99(12):8231-5.
doi: 10.1073/pnas.122238899.

ADP ribosylation of human neutrophil peptide-1 regulates its biological properties

Affiliations

ADP ribosylation of human neutrophil peptide-1 regulates its biological properties

Gregorino Paone et al. Proc Natl Acad Sci U S A. .

Abstract

In human airways, epithelial cells lining the lumen and intraluminal cells (e.g., polymorphonuclear cells) participate in the innate immune response. These cells secrete or express on their surfaces arginine-specific ADP ribosyltransferases. Defensins, antimicrobial proteins secreted by immune cells, are arginine-rich, leading us to hypothesize that ADP ribosylation could modify their biological activities. We found that an arginine-specific ADP ribosyltransferase-1 present on airway epithelial cells modifies Arg-14 of alpha defensin-1. ADP-ribosylated defensin-1 had decreased antimicrobial and cytotoxic activities but still stimulated T cell chemotaxis and IL-8 release from A549 cells. Further, ADP-ribosylated defensin-1 inhibited cytotoxic and antimicrobial activities of unmodified defensin-1. We identified ADP-ribosylated defensin-1 in bronchoalveolar lavage fluid from smokers but not from nonsmokers, confirming its existence in vivo. Thus, airway mono-ADP-ribosyltransferases could have an important regulatory role in the innate immune response through modification of alpha defensin-1 and perhaps other basic molecules, with alteration of their biological properties.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Separation of products of ART-1-catalyzed ADP-ribosylation of HNP-1 by RP-HPLC. HNP were incubated with: (a) reaction buffer alone; (b) NAD+; (c) ART-1; or (d) ART-1 and NAD+, and then analyzed by RP-HPLC. Absorbance at 210 nm (normalized to 100 full scale) is shown as a function of elution time. For a and b, full scale is 750; for c and d, 650 and 250, respectively. ADP-ribosyl-HNP-1 and HNP-1 are indicated by solid and open arrows, respectively. (Inset) Absorbance spectra of ADP-ribosyl-HNP-1 (solid line) and HNP-1 (dotted line), recorded during elution by an inline array detector.
Figure 2
Figure 2
Antimicrobial and cytotoxic activities of unmodified HNP-1 and ADP-ribosyl-HNP-1. (a) Difference in zone size (corresponding to antimicrobial activity) is the diameter of the zone of E. coli growth cleared with the indicated concentration of HNP (○) or ADP-ribosyl-HNP-1 (□) minus the diameter of the central well (3 mm). Data are means ± 1/2 range of values from two experiments. (b) A549 cells were incubated with the indicated concentrations HNP (○), ADP-ribosyl-HNP-1 (□), or synthetic HNP-1 (sHNP, Δ). Percent of lysis (cytotoxic activity) was calculated as (cpmexp − cpmspont)/(cpmmax − cpmspont) × 100; exp, experimental release; max, maximal release; spont, spontaneous release. Data are means ± SEM of values from four experiments.
Figure 3
Figure 3
Effects of ADP-ribosyl-HNP-1 on HNP-1 antimicrobial and cytotoxic activity. (a) HNP-1 (100 nM) was incubated with the indicated concentration of ADP-ribosyl-HNP-1 before addition to E. coli ATCC 43827 for radial diffusion assay. Difference in zone size was calculated as in Fig. 2 (⧫). Data are means ± SEM of values from three experiments. (b) HNP-1 (12 μM) was incubated with the indicated concentration of ADP-ribosyl-HNP-1 before addition to 51Cr-labeled A549 cells (⧫). Percentage of cell lysis was determined as in Fig. 2 to compare effects of HNP-1(○) and ADP-ribosyl-HNP-1 (□). Data are means ± 1/2 range of values from two experiments. Results were similar in another experiment by using 24 μM HNP-1.
Figure 4
Figure 4
Effects of ADP-ribosyl-HNP-1 and HNP-1 on IL-8 release by A549 cells and on T cell chemotaxis. Cells were incubated for (a) 12 or (b) 24 h with the indicated concentration of HNP-1 or ADP-ribosyl-HNP-1 before analysis of medium. IL-8 concentration in medium from cells incubated without defensins has been subtracted (at 12 h, 36.4 ± 6 pg/ml; at 24 h, 85 ± 34 pg/ml). Data are means ± 1/2 range of values from two experiments, each performed in triplicate. *, P < 0.05 for difference between IL-8 release stimulated by HNP-1 and ADP-ribosyl-HNP-1. CD3+ cells were incubated with the indicated concentrations of HNP-1 or ADP-ribosyl HNP-1 (c). We used MIP-1β (5 ng/ml) in migration medium, or migration medium alone, as positive and negative controls, respectively. Chemotaxis percentage was calculated as: (number of cells migrated to the lower chamber in the experimental conditions − number of cells migrated in the negative control)/(number of cells migrated in the positive control − number of cells migrated in negative control) × 100. Data are means ± SEM values from four experiments, each performed in duplicate.
Figure 5
Figure 5
Characterization of ADP-ribosyl-HNP-1 from BAL fluid by RP-HPLC, MALDI, and enzymatic digestion. (a) Alignment of RP-HPLC chromatograms of products of ART-1-catalyzed ADP-ribosylation of HNP-1 (continuous line) and a chromatogram of a BAL sample from a smoker (dotted line). Arrows indicate elution times of ADP-ribosyl-HNP-1 and HNP-1. (b) (i) The peak with elution time compatible with ADP-ribosyl-HNP-1 (46.5 min), analyzed by MALDI-MS, shows a mass of 3,983 Da, consistent with ADP-ribosyl-HNP-1 (calculated 3,983 Da). (ii) Incubation of ADP-ribosyl-HNP-1 with pyrophosphatase and alkaline phosphatase produced ribosyl-HNP-1 (calculated 3,574 Da). (iii) ADP-ribosylarginine hydrolase cleaved the ribose-arginine linkage to release HNP-1 (calculated 3,443 Da). m/z is on the x axis.

Similar articles

Cited by

References

    1. Nakamura H, Yoshimura K, Jaffe H A, Crystal R G. J Biol Chem. 1991;266:19611–19617. - PubMed
    1. Rihman-Eisenstat J B, Jorens P G, Herbert C A, Ueki I, Nadel J A. Am J Physiol. 1993;264:L413–L418. - PubMed
    1. Ganz T. Infect Immun. 1987;55:568–571. - PMC - PubMed
    1. Pardi A, Zhang X L, Selsted M E, Skalicky J J, Yip P F. Biochemistry. 1992;31:11357–11364. - PubMed
    1. Kagan B L, Selsted M E, Ganz T, Leherer R I. Proc Natl Acad Sci USA. 1990;87:210–214. - PMC - PubMed

MeSH terms

LinkOut - more resources